WWC1

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, WWC1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated WWC1 data layer compared with 23 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher WWC1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated WWC1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.

HNSC, LSCC, and PDAC are the cancer types where WWC1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCOSMedianIV0.9330.412<.00145view →
LSCCDFSMedianIII,IV0.8680.359.00616view →
PDACDFSMedianIII,IV0.8910.317.00913view →
CCRCCOSTertileII,III,IV0.9850.133.0277view →
GBMOSQuartileAll0.1980.608.0166view →
LUADOSMedianAll0.8830.788.0365view →
Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

WWC1–HNSC (OS)

Kaplan–Meier survival curve for WWC1 mass-spec protein-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration